Cargando…
Fetal RHD Screening in RH1 Negative Pregnant Women: Experience in Switzerland
RH1 incompatibility between mother and fetus can cause hemolytic disease of the fetus and newborn. In Switzerland, fetal RHD genotyping from maternal blood has been recommended from gestational age 18 onwards since the year 2020. This facilitates tailored administration of RH immunoglobulin (RHIG) o...
Autores principales: | Schimanski, Bernd, Kräuchi, Rahel, Stettler, Jolanda, Lejon Crottet, Sofia, Niederhauser, Christoph, Clausen, Frederik Banch, Fontana, Stefano, Hodel, Markus, Amylidi-Mohr, Sofia, Raio, Luigi, Abbal, Claire, Henny, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604374/ https://www.ncbi.nlm.nih.gov/pubmed/37893020 http://dx.doi.org/10.3390/biomedicines11102646 |
Ejemplares similares
-
Reducing the Risk of Preterm Preeclampsia: Comparison of Two First Trimester Screening and Treatment Strategies in a Single Centre in Switzerland
por: Amylidi-Mohr, Sofia, et al.
Publicado: (2021) -
First‐trimester glycosylated hemoglobin (HbA1c) and maternal characteristics in the prediction of gestational diabetes: An observational cohort study
por: Amylidi‐Mohr, Sofia, et al.
Publicado: (2022) -
Pre-Analytical Conditions in Non-Invasive Prenatal Testing of Cell-Free Fetal RHD
por: Clausen, Frederik Banch, et al.
Publicado: (2013) -
RHD genotyping to resolve weak and discrepant RhD patient phenotypes
por: Barriteau, Christina M., et al.
Publicado: (2022) -
Single-strained DNA aptamers mask RhD antigenic epitopes on human RhD(+) red blood cells to escape alloanti-RhD immunological recognition
por: Zhang, Yinze, et al.
Publicado: (2020)